These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39179712)

  • 1. Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
    Simone M; Lucisano G; Guerra T; Paolicelli D; Rocca MA; Brescia Morra V; Patti F; Annovazzi P; Gasperini C; De Luca G; Ferraro D; Margari L; Granella F; Pozzilli C; Romano S; Perini P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Lugaresi A; Portaccio E; Filippi M; Amato MP; Iaffaldano P;
    J Neurol; 2024 Oct; 271(10):6782-6790. PubMed ID: 39179712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Sclerosis Progression and Relapse Activity in Children.
    Iaffaldano P; Portaccio E; Lucisano G; Simone M; Manni A; Guerra T; Paolicelli D; Betti M; De Meo E; Pastò L; Razzolini L; Rocca MA; Ferrè L; Brescia Morra V; Patti F; Zaffaroni M; Gasperini C; De Luca G; Ferraro D; Granella F; Pozzilli C; Romano S; Gallo P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Banfi P; Lugaresi A; Totaro R; Spitaleri D; Cocco E; Di Palma F; Maimone D; Valentino P; Torri Clerici V; Protti A; Maniscalco GT; Salemi G; Pesci I; Aguglia U; Lepore V; Filippi M; Trojano M; Amato MP;
    JAMA Neurol; 2024 Jan; 81(1):50-58. PubMed ID: 38010712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
    Portaccio E; Betti M; De Meo E; Addazio I; Pastò L; Razzolini L; Totaro R; Spitaleri D; Lugaresi A; Cocco E; Onofrj M; Di Palma F; Patti F; Maimone D; Valentino P; Torri Clerici V; Protti A; Ferraro D; Lus G; Maniscalco GT; Brescia Morra V; Salemi G; Granella F; Pesci I; Bergamaschi R; Aguglia U; Vianello M; Simone M; Lepore V; Iaffaldano P; Comi G; Filippi M; Trojano M; Amato MP;
    J Neurol; 2024 Aug; 271(8):5074-5082. PubMed ID: 38805052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis.
    Puthenparampil M; Gaggiola M; Ponzano M; Zanotelli G; Miscioscia A; Nosadini M; Di Paola A; Sartori S; Perini P; Rinaldi F; Bovis F; Gallo P
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200303. PubMed ID: 39141876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
    Ozakbas S; Kaya E; Aslan T; Ozdogar AT; Baba C
    Mult Scler Relat Disord; 2024 Oct; 90():105810. PubMed ID: 39180837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    Lorefice L; Ferraro OE; Fenu G; Amato MP; Bresciamorra V; Conte A; De Luca G; Ferraro D; Filippi M; Gazzola P; Iaffaldano P; Inglese M; Lus G; Marfia GA; Patti F; Pesci I; Salemi G; Trojano M; Zaffaroni M; Monti MC; Cocco E;
    J Neurol; 2024 Apr; 271(4):1630-1637. PubMed ID: 38172380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
    Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
    Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
    Tur C; Carbonell-Mirabent P; Cobo-Calvo Á; Otero-Romero S; Arrambide G; Midaglia L; Castilló J; Vidal-Jordana Á; Rodríguez-Acevedo B; Zabalza A; Galán I; Nos C; Salerno A; Auger C; Pareto D; Comabella M; Río J; Sastre-Garriga J; Rovira À; Tintoré M; Montalban X
    JAMA Neurol; 2023 Feb; 80(2):151-160. PubMed ID: 36534392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disability progression of pediatric-onset multiple sclerosis.
    McKay KA; Hillert J; Manouchehrinia A
    Neurology; 2019 Jun; 92(24):e2764-e2773. PubMed ID: 31092624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.
    Baroncini D; Simone M; Iaffaldano P; Brescia Morra V; Lanzillo R; Filippi M; Romeo M; Patti F; Chisari CG; Cocco E; Fenu G; Salemi G; Ragonese P; Inglese M; Cellerino M; Margari L; Comi G; Zaffaroni M; Ghezzi A;
    JAMA Neurol; 2021 Jun; 78(6):726-735. PubMed ID: 33938921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
    McKay KA; Ernstsson O; Manouchehrinia A; Olsson T; Hillert J
    Neurology; 2020 Mar; 94(9):e932-e941. PubMed ID: 31732567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
    Harding KE; Liang K; Cossburn MD; Ingram G; Hirst CL; Pickersgill TP; Te Water Naude J; Wardle M; Ben-Shlomo Y; Robertson NP
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):141-7. PubMed ID: 23154123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
    Usta NC; Boz C; Terzi M
    Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients.
    Menascu S; Khavkin Y; Zilkha-Falb R; Dolev M; Magalashvili D; Achiron A; Gurevich M
    Ann Clin Transl Neurol; 2021 Jan; 8(1):81-94. PubMed ID: 33197148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What an adult multiple sclerosis registry can tell us about pediatric onset multiple sclerosis?
    Alkolfat F; Said S; Mekky J; Eldeeb H
    Mult Scler Relat Disord; 2023 Nov; 79():104962. PubMed ID: 37714097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis.
    Chen B; Ji SQ; Shen F; Tian DS; Bu BT
    Mult Scler Relat Disord; 2022 Mar; 59():103555. PubMed ID: 35093839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.